Home-JAWORSKI ASSOCIATES LLC

Home-JAWORSKI ASSOCIATES LLC

JAWORSKI ASSOCIATES LLC

SERVICES

Professional Pharmaceutical Training
Professional Expert Witness Services
Professional writing

CLIENTS

Food and Drug Administration
Parenteral Drug Association

PROJECTS

Sterile Drug Compounding Course

ABOUT US

Beverly Jaworski, President
Beverly has 30 years experience in the field of education. Her expertise lies in the fields of educational research,curriculum and course development, and classroom/laboratory management. She has a BA from Mercyhurst University and a MS from Montana State University. These degrees as well as her experience qualifies her to work with children, adolescents, and adults in their quest for learning. For the last 10 years she has concentrated on enhancing science and STEM education. In the future she will be researching ways literature can be used to enhance the study of science and STEM, and writing books that can incorporate storytelling with the understanding our world.

David Jaworski, Vice President
David has extensive experience in pharmaceutical manufacturing, international business management, and regulatory science. With a background of over 38 years in industry and most recently at the FDA, he strives at the PDA to help members apply world class pharmaceutical and biotechnology practices, principles and methods to improve the quality of manufacturing facilities, employees, processes, and drug products. He has a Bachelor of Science Degree in Microbiology from Pennsylvania State University and a Master of Business Administration Degree in Operations and Management from Syracuse University. He has worked for major pharmaceutical companies, consultancies, and also at biotech start-up companies. At the FDA he started his career as a Consumer Safety Officer working in the CDER Office of Compliance and retired from the FDA as a Senior Policy Advisor in the Office of Manufacturing Quality. His expertise includes both sterile and non-sterile products; biotech APIís, devices, pharmacy compounding, as well as building new sterile facilities and innovative manufacturing processes. He has worked on the PDA/FDA Joint Conference planning committee, is a past Co-Chair, and has been a speaker at several PDA conferences.